108 related articles for article (PubMed ID: 7490679)
1. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas.
Jiang SX; Sato Y; Kuwao S; Kameya T
J Pathol; 1995 Oct; 177(2):135-8. PubMed ID: 7490679
[TBL] [Abstract][Full Text] [Related]
2. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
3. High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.
Higashiyama M; Doi O; Kodama K; Yokouchi H; Tateishi R
Anticancer Res; 1995; 15(2):503-5. PubMed ID: 7763030
[TBL] [Abstract][Full Text] [Related]
4. Frequent loss of Fas expression and function in human lung tumours with overexpression of FasL in small cell lung carcinoma.
Viard-Leveugle I; Veyrenc S; French LE; Brambilla C; Brambilla E
J Pathol; 2003 Oct; 201(2):268-77. PubMed ID: 14517844
[TBL] [Abstract][Full Text] [Related]
5. Analysis of p53, K-ras-2, and C-raf-1 in pulmonary neuroendocrine tumors. Correlation with histological subtype and clinical outcome.
Przygodzki RM; Finkelstein SD; Langer JC; Swalsky PA; Fishback N; Bakker A; Guinee DG; Koss M; Travis WD
Am J Pathol; 1996 May; 148(5):1531-41. PubMed ID: 8623922
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 protein expression in lung cancer and close correlation with neuroendocrine differentiation.
Jiang SX; Kameya T; Sato Y; Yanase N; Yoshimura H; Kodama T
Am J Pathol; 1996 Mar; 148(3):837-46. PubMed ID: 8774138
[TBL] [Abstract][Full Text] [Related]
7. Small cell carcinomas of the lung express the Bcl-2 protein.
Ben-Ezra JM; Kornstein MJ; Grimes MM; Krystal G
Am J Pathol; 1994 Nov; 145(5):1036-40. PubMed ID: 7977636
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 expression as a predictor of chemosensitivities and survival in small cell lung cancer.
Takayama K; Ogata K; Nakanishi Y; Yatsunami J; Kawasaki M; Hara N
Cancer J Sci Am; 1996; 2(4):212-6. PubMed ID: 9166534
[TBL] [Abstract][Full Text] [Related]
9. Expression of bcl-2 oncoprotein in renal cell tumours.
Paraf F; Gogusev J; Chrétien Y; Droz D
J Pathol; 1995 Nov; 177(3):247-52. PubMed ID: 8551386
[TBL] [Abstract][Full Text] [Related]
10. Abnormal p53 expression in lung neuroendocrine tumors. Diagnostic and prognostic implications.
Roncalli M; Doglioni C; Springall DR; Papotti M; Pagani A; Polak JM; Ibrahim NB; Coggi G; Viale G
Diagn Mol Pathol; 1992 Jun; 1(2):129-35. PubMed ID: 1364172
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological study on primary lung cancer--immunohistochemical expression of p53 suppressor gene and bcl-2 oncogene in relation to prognosis].
Irie K; Ishida H; Furukawa T; Koyanagi K; Miyamoto Y
Rinsho Byori; 1996 Jan; 44(1):32-41. PubMed ID: 8691638
[TBL] [Abstract][Full Text] [Related]
12. Nuclear and cytoplasmic bcl-2 expression in endometrial hyperplasia and adenocarcinoma.
Chan WK; Mole MM; Levison DA; Ball RY; Lu QL; Patel K; Hanby AM
J Pathol; 1995 Nov; 177(3):241-6. PubMed ID: 8551385
[TBL] [Abstract][Full Text] [Related]
13. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
14. Expression of vesicular monoamine transporters, synaptosomal-associated protein 25 and syntaxin1: a signature of human small cell lung carcinoma.
Graff L; Castrop F; Bauer M; Höfler H; Gratzl M
Cancer Res; 2001 Mar; 61(5):2138-44. PubMed ID: 11280778
[TBL] [Abstract][Full Text] [Related]
15. Distribution of Bcl-2 gene expression and its prognostic value in non-small cell lung cancer.
Yilmaz A; Savaş I; Dizbay Sak S; Güngör A; Kaya A; Serinsöz E; Savaş B
Tuberk Toraks; 2005; 53(4):323-9. PubMed ID: 16456730
[TBL] [Abstract][Full Text] [Related]
16. Analysis of c-kit protein expression in small-cell lung carcinoma and its implication for prognosis.
Naeem M; Dahiya M; Clark JI; Creech SD; Alkan S
Hum Pathol; 2002 Dec; 33(12):1182-7. PubMed ID: 12514786
[TBL] [Abstract][Full Text] [Related]
17. Differences in expression of pro-caspases in small cell and non-small cell lung carcinoma.
Joseph B; Ekedahl J; Sirzen F; Lewensohn R; Zhivotovsky B
Biochem Biophys Res Commun; 1999 Aug; 262(2):381-7. PubMed ID: 10462484
[TBL] [Abstract][Full Text] [Related]
18. Apoptotic markers p53, Bcl-2 and Bax in primary lung cancer.
Porebska I; Wyrodek E; Kosacka M; Adamiak J; Jankowska R; Harłozińska-Szmyrka A
In Vivo; 2006; 20(5):599-604. PubMed ID: 17091766
[TBL] [Abstract][Full Text] [Related]
19. Apoptosis in operated small cell lung carcinoma is inversely related to tumour necrosis and p53 immunoreactivity.
Eerola AK; Törmänen U; Rainio P; Sormunen R; Bloigu R; Vähäkangas K; Lehto VP; Soini Y; Pääkkö P
J Pathol; 1997 Feb; 181(2):172-7. PubMed ID: 9120721
[TBL] [Abstract][Full Text] [Related]
20. Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.
Yaren A; Oztop I; Kargi A; Ulukus C; Onen A; Sanli A; Binicier O; Yilmaz U; Alakavuklar M
Int J Clin Pract; 2006 Jun; 60(6):675-82. PubMed ID: 16805752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]